The Cooper Companies (COO) Q4 earnings: Taking a look at key metrics versus estimates

For the quarter ended October 2025, The Cooper Companies (COO) reported revenue of $1.07 billion, up 4.6% over the same period last year. EPS came in at $1.15, compared to $1.04 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $1.06 billion, representing a surprise of +0.45%. The company delivered an EPS surprise of +3.6%, with the consensus EPS estimate being $1.11.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how The Cooper Companies performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenue by geography- Americas: $285.1 million versus $291.49 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +5.4% change.
• Revenue by geography- Asia Pacific: $147.4 million versus the two-analyst average estimate of $139.8 million. The reported number represents a year-over-year change of -1.3%.
• Revenue by geography- EMEA: $277.1 million versus the two-analyst average estimate of $269.49 million. The reported number represents a year-over-year change of +8%.
• Revenue by category- CVI: $709.6 million compared to the $707.83 million average estimate based on five analysts. The reported number represents a change of +4.9% year over year.
• Revenue by category- CSI: $355 million versus $352.65 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +3.8% change.
• Revenue by category- CSI- Office and surgical: $214.6 million versus $208.89 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +5.8% change.
• Revenue by category- CSI- Fertility: $141 million compared to the $144.03 million average estimate based on four analysts. The reported number represents a change of +1.3% year over year.
• Revenue by category- CVI- Sphere, other: $365 million compared to the $362.34 million average estimate based on four analysts. The reported number represents a change of +3.3% year over year.
• Revenue by category- CVI- Toric and multifocal: $344.6 million versus $346.45 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +6.6% change.